Gene mutations and p53 protein levels in squamous cell carcinomas
Author Information
Author(s): J.E. Burns, M.C. Baird, L.J. Clark, P.A. Burns, K. Edington, C. Chapman, R. Mitchell, G. Robertson, D. Soutar, E.K. Parkinson
Primary Institution: Cancer Research Campaign, Beatson Institute for Cancer Research
Hypothesis
The study investigates the presence of p53 mutations and protein levels in human squamous cell carcinomas and their cell lines.
Conclusion
The study found that a significant number of squamous cell carcinomas and their cell lines exhibit high levels of p53 protein and mutations in the p53 gene.
Supporting Evidence
- 33% of human squamous cell carcinomas showed elevated p53 protein levels.
- 50% of SCC cell lines exhibited high p53 protein levels.
- Mutations in the p53 gene were confirmed in several cell lines.
- Some mutations were found in a region known to be a hotspot for p53 mutations.
- All SCC lines tested were negative for HPV types 16 and 18.
Takeaway
Some cancers have a broken gene called p53 that helps control cell growth, and this study found many cases where this gene was mutated or not working properly.
Methodology
The study used immunocytochemical techniques and Western blotting to analyze p53 protein levels and direct sequencing to identify mutations in the p53 gene.
Limitations
The study did not explore the potential presence of other HPV types that could affect p53 levels.
Want to read the original?
Access the complete publication on the publisher's website